← Back to contracts

Diabetes Research Centers (P30 Clinical Trial Optional)

US National Institutes of Health (NIH) – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant open #RFA-DK-26-310
Response due Jan 27, 2027 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting applications for Diabetes Research Centers under the P30 Center Core Grants mechanism. Clinical trials are optional under this funding opportunity. The program supports the establishment or continuation of research centers focused on diabetes, likely including core resources, pilot projects, and collaborative infrastructure. This is a federal grant opportunity posted on Grants.gov with a multi-year application window running through January 2027.

What they want

Technical requirements
  • Applications must conform to NIH P30 Center Core Grant requirements
  • Clinical trials inclusion is optional
  • Must align with diabetes research focus area of NIDDK

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

  • Very long open window (over 13 months) may indicate rolling or multi-cycle submission rather than a competitive single deadline — review for multiple due dates within the FOA
  • Opportunity text is sparse; full FOA requirements and eligibility details are not provided in the excerpt, limiting full risk assessment

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Diabetes Research Centers (P30 Clinical Tr…
Due Jan 27
Onboard